ID
int64 1
9.11k
| age
float64 18
102
| death
int64 0
1
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| d.time
int64 3
2.03k
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4,801 | 54.59497 | 1 | male | 0 | 5 | 420 | Colon Cancer | Cancer | 1 | 16 | >$50k | 0 | 13,289 | 6,735.8594 | 3,071 | 11 | white | 13.298828 | 13 | 0.875 | 0.718994 | 1 | 0 | 0 | metastatic | 0.8 | 0.65 | no dnr | 5 | 56 | 6.099609 | 145 | 55 | 38.69531 | 140 | 1.799805 | 0.799927 | 1.5 | 143 | 7.449219 | 289 | 39 | 1,340 | 0 | 0 | no(M2 and SIP pres) | 0 |
4,802 | 45.85397 | 1 | male | 0 | 5 | 224 | Lung Cancer | Cancer | 1 | 12 | under $11k | 0 | 4,246 | 3,055.1699 | 3,030 | 10 | white | 21.296875 | 22 | 0.666992 | 0.365967 | 1 | 0 | 0 | metastatic | 0 | 0 | no dnr | 5 | 45 | 7.699219 | 140 | 5 | 39.29688 | 128 | null | null | 1.099854 | 129 | 7.479492 | 112 | 11 | 4,760 | 0 | 0 | null | 0 |
4,803 | 70.06995 | 1 | male | 1 | 4 | 4 | Coma | Coma | 1 | null | null | 94 | 31,884 | 17,663.625 | 17,761 | 23 | white | 22.199219 | 29 | 0.181 | 0.122986 | 4 | 0 | 0 | no | null | null | dnr after sadm | 2 | 93 | 7 | 72 | 24 | 36.19531 | null | 3.399902 | 0.699951 | 4.699219 | 143 | null | 281 | 54 | 1,250 | null | null | <2 mo. follow-up | 2.388184 |
4,804 | 78.52997 | 1 | male | 1 | 16 | 16 | Coma | Coma | 2 | 16 | $11-$25k | 44 | 295,624 | 174,851 | 163,726 | 43.666657 | white | 29 | 58 | 0.097992 | 0.058998 | 67 | 0 | 0 | no | 0.3 | 0.027 | dnr after sadm | 12 | 133 | 0.099991 | 110 | 43 | 36 | 116.3125 | null | 20.5 | 1.299805 | 152 | 7.459961 | 231 | 51 | 3,460 | null | 0 | <2 mo. follow-up | 0 |
4,805 | 43.95599 | 0 | male | 0 | 7 | 814 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | $25-$50k | 0 | 22,270 | 14,354.4141 | 18,046 | 21 | black | 19.699219 | 27 | 0.903931 | 0.869995 | 1 | 0 | 0 | no | null | null | no dnr | 7 | 150 | 7.899414 | 105 | 34 | 36.29688 | 260 | 2.899902 | 1.099854 | 2.299805 | 142 | 7.369141 | 98 | 58 | 1,490 | 1 | 0 | null | 0 |
4,806 | 47.85797 | 0 | male | 0 | 19 | 815 | Cirrhosis | COPD/CHF/Cirrhosis | 3 | 10 | null | 0 | 29,024 | 17,875.7656 | 21,016 | 11 | white | 18 | 14 | 0.870972 | 0.785889 | 1 | 1 | 0 | no | 0.95 | 0.75 | no dnr | 19 | 62 | 9.298828 | 140 | 20 | 35 | 237.125 | 2.5 | 4 | 3 | 142 | 7.509766 | 104 | 67 | 3,400 | 2 | 1 | no(M2 and SIP pres) | 1 |
4,807 | 46.155 | 0 | male | 0 | 20 | 815 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 10 | null | 0 | 115,662 | 66,758.75 | 65,619 | 30.666656 | white | 21 | 37 | 0.85498 | 0.804932 | 11 | 0 | 0 | no | 0.95 | 0.94 | no dnr | 20 | 58 | 11.298828 | 115 | 41 | 36.69531 | 63 | null | 14.398438 | 2.399902 | 150 | 7.339844 | 90 | 10 | 355 | null | 3 | no(M2 and SIP pres) | 3 |
4,808 | 45.60999 | 0 | female | 0 | 13 | 814 | COPD | COPD/CHF/Cirrhosis | 2 | 12 | null | 0 | 20,191 | 12,313.1172 | 13,961 | 15 | hispanic | 17.097656 | 27 | 0.942993 | 0.902954 | 1 | 0 | 0 | no | 0.99 | 0.99 | no dnr | 13 | 48 | 14.398438 | 105 | 11 | 38.39844 | 184.4375 | null | null | 2.099609 | 137 | 7.439453 | 150 | 51 | 2,640 | 1 | 1 | null | 1 |
4,809 | 66.95099 | 1 | female | 1 | 5 | 5 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | under $11k | 61 | 107,918 | 56,022.4062 | 59,728 | 52 | white | 46.09375 | 80 | 0.011999 | 0.002 | 16 | 1 | 0 | no | 0 | 0 | dnr after sadm | 2 | 100 | 14.898438 | 125 | 14 | 38.79688 | 376.625 | null | null | 1 | 137 | 7.419922 | 244 | 19 | 2,235 | null | null | <2 mo. follow-up | 2.954102 |
4,810 | 68.26599 | 1 | female | 0 | 10 | 117 | Cirrhosis | COPD/CHF/Cirrhosis | 1 | 12 | null | 0 | 8,255 | 6,076.8086 | 6,907 | 7.5 | white | 25 | 28 | 0.635986 | 0.453979 | 1 | 0 | 0 | no | 0.8 | 0.5 | no dnr | 10 | 78 | 4.199219 | 120 | 10 | 35.59375 | null | null | 0.899902 | 3.699707 | 126 | null | 180 | 83 | 4,035 | 1 | null | no(M2 and SIP pres) | 1.166748 |
4,811 | 50.46698 | 0 | male | 0 | 19 | 812 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 7 | $11-$25k | 0 | 55,520 | 34,977 | 38,101 | 13.333328 | black | 22.097656 | 26 | 0.840942 | 0.786987 | 6 | 0 | 0 | no | 0.5 | 0.4 | no dnr | 19 | 108 | 5.699219 | 80 | 20 | 36.09375 | 185.6875 | 3.399902 | 0.5 | 3 | 136 | 7.399414 | 130 | 47 | 4,500 | null | 0 | no(M2 and SIP pres) | 0 |
4,812 | 65.79596 | 1 | female | 1 | 11 | 11 | Lung Cancer | Cancer | 1 | 12 | $11-$25k | 0 | 10,715 | 7,155.7812 | 7,148 | 9.5 | white | 33.796875 | 31 | 0.255981 | 0.033997 | 1 | 1 | 0 | metastatic | 0.4 | 0.2 | dnr after sadm | 10 | 112 | 1.699951 | 65 | 26 | 36.59375 | 283.3125 | null | 1.399902 | 0.599976 | 146 | 7.449219 | 93 | 21 | 3,720 | 4 | 0 | <2 mo. follow-up | 0 |
4,813 | 70.25098 | 1 | female | 0 | 16 | 262 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 11 | null | 9 | 68,825 | 38,212.2188 | 37,550 | 16 | black | 21.699219 | 22 | 0.79895 | 0.73291 | 1 | 1 | 0 | no | 0.7 | 0.65 | no dnr | 16 | 103 | 16 | 102 | 24 | 36.79688 | 159.15625 | null | 1 | 0.699951 | 145 | 7.329102 | 237 | 6 | 950 | 0 | 0 | no(M2 and SIP pres) | 0 |
4,814 | 56.76398 | 0 | male | 0 | 17 | 810 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 10 | $25-$50k | 0 | 68,058 | 39,405.25 | 37,896 | 16.666656 | white | 24.898438 | 25 | 0.726929 | 0.642944 | 7 | 0 | 0 | yes | 0.99 | 0.97 | no dnr | 17 | 65 | 7.699219 | 55 | 20 | 36.39844 | null | null | 0.5 | 1.199951 | 136 | null | 80 | 26 | 950 | 0 | 0 | no(M2 and SIP pres) | 0 |
4,815 | 59.35397 | 1 | male | 0 | 3 | 315 | COPD | COPD/CHF/Cirrhosis | 3 | 11 | $25-$50k | 0 | 2,370 | 1,662.3418 | 1,842 | 8 | white | 9.599609 | 18 | 0.949951 | 0.91394 | 1 | 0 | 0 | no | 0.5 | 0.3 | no dnr | 3 | 112 | 15.798828 | 130 | 24 | 36.29688 | 87.6875 | 2.899902 | 3.399902 | 1.199951 | 140 | 7.40918 | 202 | 72 | 3,320 | 0 | 0 | no(M2 and SIP pres) | 0 |
4,816 | 52.465 | 0 | male | 0 | 22 | 809 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | null | 0 | 109,993 | 64,156.375 | 64,956 | 39.666657 | white | 31.796875 | 54 | 0.672974 | 0.576904 | 6 | 1 | 0 | no | null | null | no dnr | 22 | 115 | 13.099609 | 120 | 24 | 36.5 | 300 | 3.699707 | 0.799927 | 1 | 138 | 7.30957 | 132 | 14 | 900 | null | 1 | no(M2 and SIP pres) | 1 |
4,817 | 61.41498 | 1 | male | 1 | 43 | 43 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | null | 0 | 316,205 | 172,765.625 | 148,295 | 45 | white | 33.898438 | 54 | 0.473999 | 0.35498 | 9 | 0 | 0 | yes | 0.5 | 0.5 | dnr after sadm | 40 | 64 | 15.5 | 98 | 20 | 35.19531 | 480.9375 | 2.299805 | 7.399414 | 2.299805 | 135 | 7.509766 | 114 | 74 | 305 | null | 0 | <2 mo. follow-up | 0 |
4,818 | 62.35999 | 1 | female | 1 | 15 | 15 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 13 | under $11k | 0 | 64,166 | 38,736.25 | 39,179 | 29.333328 | white | 17.199219 | 38 | 0.861938 | 0.813965 | 1 | 0 | 0 | yes | 0.5 | 0.25 | dnr after sadm | 10 | 101 | 16.898438 | 65 | 14 | 36.5 | 304.75 | null | 0.599976 | 2 | 130 | 7.469727 | 177 | 58 | 3,135 | null | null | <2 mo. follow-up | 1.850586 |
4,819 | 84.07898 | 1 | female | 1 | 7 | 7 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | null | null | 0 | 76,664 | null | null | 33 | white | 21.296875 | 35 | 0.715942 | 0.628906 | 11 | 0 | 0 | no | 0.5 | 0.45 | dnr after sadm | 2 | 98 | 7.299805 | 72 | 16 | 36.39844 | null | 4.5 | 0.699951 | 1.5 | 142 | null | 105 | 19 | null | null | null | <2 mo. follow-up | 2.198242 |
4,820 | 36.82397 | 0 | male | 0 | 12 | 808 | Cirrhosis | COPD/CHF/Cirrhosis | 4 | 7 | under $11k | 0 | 25,253 | 15,538.0781 | 15,734 | 17.5 | white | 22.5 | 47 | 0.865967 | 0.777954 | 1 | 0 | 0 | no | 0.6 | 0.45 | no dnr | 12 | 65 | 22.597656 | 60 | 10 | 38.29688 | 137.5 | 3 | 0.599976 | 1.5 | 136 | 7.489258 | 261 | 30 | 2,695 | 6 | 0 | no(M2 and SIP pres) | 0 |
4,821 | 51.16998 | 0 | female | 0 | 13 | 807 | MOSF w/Malig | ARF/MOSF | 1 | 14 | $11-$25k | 0 | 26,200 | 16,062 | 14,772 | 22.5 | white | 31.597656 | 51 | 0.512939 | 0.395996 | 2 | 0 | 0 | yes | 0.5 | 0.5 | no dnr | 13 | 69 | 3.399902 | 64 | 16 | 36.29688 | null | 2.699707 | null | 0.899902 | 124 | null | 78 | 11 | 1,750 | 1 | 1 | SIP>=30 | 1 |
4,822 | 64.20496 | 0 | female | 0 | 8 | 807 | MOSF w/Malig | ARF/MOSF | 1 | 0 | null | 0 | 32,290 | null | null | 22.5 | black | 29.699219 | 25 | 0.521973 | 0.405945 | 3 | 0 | 0 | yes | 0.9 | 0.85 | no dnr | 8 | 108 | 19.597656 | 65 | 8 | 36.19531 | 388 | null | 0.399963 | 8.298828 | 136 | 7.329102 | 146 | 54 | 835 | null | 1 | null | 1 |
4,823 | 50.76199 | 1 | female | 1 | 3 | 3 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | null | null | 100 | 8,819 | 5,596.2266 | 4,756 | 20 | black | 52 | 53 | 0.001 | 0 | 1 | 1 | 0 | no | null | null | dnr after sadm | 2 | 58 | 16.199219 | 125 | 12 | 39.5 | 286.625 | null | null | 5.399414 | 133 | 7.40918 | 156 | 88 | 70 | null | null | <2 mo. follow-up | 3.615234 |
4,824 | 63.67398 | 0 | female | 0 | 10 | 806 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 16 | $25-$50k | 0 | 27,389 | 15,589.3984 | 18,273 | 15 | white | 24.699219 | 24 | 0.776978 | 0.703979 | 3 | 0 | 0 | no | 0.9 | 0.85 | no dnr | 10 | 83 | 7.599609 | 75 | 20 | 35.5 | null | null | null | 1.599854 | 141 | null | 97 | 13 | null | 0 | null | no(M2 and SIP pres) | 0.494751 |
4,825 | 68.58295 | 0 | female | 0 | 4 | 806 | Lung Cancer | Cancer | 1 | 11 | under $11k | 0 | 10,106 | 5,244.6758 | 3,853 | 15 | white | 11.199219 | 5 | 0.800903 | 0.576904 | 1 | 0 | 0 | metastatic | 0.9 | 0.6 | no dnr | 4 | 72 | 9.199219 | 145 | 24 | 35.59375 | 309.5 | null | 1 | 1.599854 | 137 | 7.529297 | 157 | 41 | 1,730 | 0 | 0 | adl>=4 (>=5 if sur) | 0 |
4,826 | 79.58099 | 1 | male | 1 | 4 | 4 | Coma | Coma | 2 | null | null | 100 | 36,162 | 21,214.6406 | 19,782 | 35 | white | 60.398438 | 84 | 0 | 0 | 13 | 1 | 1 | no | 0.05 | 0.05 | dnr after sadm | 2 | 50 | 11 | 80 | 22 | 35.79688 | 264 | null | null | 3.099609 | 132 | 7.449219 | 104 | 52 | 770 | null | null | <2 mo. follow-up | 4.392578 |
4,827 | 83.58398 | 0 | female | 0 | 17 | 806 | Coma | Coma | 0 | 17 | >$50k | 44 | 73,879 | 43,665.25 | 45,931 | 13.666664 | white | 17.898438 | 34 | 0.366943 | 0.292969 | 14 | 0 | 0 | no | 0.6 | 0.5 | dnr after sadm | 3 | 73 | 5.599609 | 80 | 22 | 35.39844 | 239.125 | 3.399902 | null | 1.599854 | 137 | 7.389648 | 90 | 41 | 850 | null | 1 | adl>=4 (>=5 if sur) | 1 |
4,828 | 34.439 | 0 | male | 0 | 25 | 805 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | $25-$50k | 94 | null | null | null | 29.25 | white | 25.398438 | 28 | 0.55896 | 0.44696 | 3 | 0 | 0 | no | 0.8 | 0.75 | no dnr | 25 | 75 | 10.898438 | 125 | 25 | 38.59375 | 438.0625 | null | 0.599976 | 3.5 | 137 | 7.329102 | 108 | 29 | 790 | null | 0 | null | 0 |
4,829 | 53.40198 | 1 | male | 0 | 4 | 102 | Lung Cancer | Cancer | 1 | 14 | >$50k | 0 | 9,731 | 5,429.5742 | 3,823 | 14 | white | 17.597656 | 5 | 0.723999 | 0.448975 | 1 | 0 | 0 | metastatic | 0.8 | 0.6 | no dnr | 4 | 60 | 10.398438 | 60 | 25 | 35.89844 | 362.8125 | 1.5 | 2.599609 | 5.299805 | 125 | 7.339844 | 206 | 72 | 94 | 0 | 0 | no(M2 and SIP pres) | 0 |
4,830 | 44.81897 | 0 | female | 0 | 16 | 803 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 9 | null | 0 | 54,182 | 31,910.4219 | 30,886 | 31.666656 | black | 38 | 51 | 0.61499 | 0.509888 | 2 | 0 | 0 | no | 0.4 | 0.4 | no dnr | 16 | 153 | 16.5 | 115 | 29 | 39.09375 | 283.3125 | null | 0.899902 | 0.799927 | 138 | 7.419922 | 173 | 8 | 4,400 | null | 1 | no(M2 and SIP pres) | 1 |
4,831 | 74.78699 | 1 | male | 1 | 8 | 8 | CHF | COPD/CHF/Cirrhosis | 4 | 14 | null | 0 | 35,324 | null | null | 33.5 | white | 23.398438 | 51 | 0.783936 | 0.653931 | 1 | 1 | 0 | no | 0.2 | 0.1 | dnr after sadm | 7 | 72 | 18.796875 | 125 | 32 | 36.59375 | 266.625 | 1.899902 | 1.299805 | 3.299805 | 136 | 7.469727 | 99 | 74 | 120 | 1 | null | <2 mo. follow-up | 1.166748 |
4,832 | 69.97894 | 1 | male | 1 | 6 | 6 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | under $11k | 26 | 27,063 | 16,028.375 | 20,265 | 28 | white | 25.5 | 40 | 0.641968 | 0.541992 | 3 | 0 | 0 | no | 0.7 | 0.5 | dnr before sadm | -1 | 70 | 21.597656 | 105 | 24 | 35.89844 | null | null | 20.296875 | 2.599609 | 138 | null | 92 | 98 | 1,090 | null | 2 | <2 mo. follow-up | 2 |
4,833 | 25.254 | 0 | female | 0 | 73 | 803 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 9 | under $11k | 0 | null | null | null | 45.5 | black | 45.5 | 71 | 0.522949 | 0.406982 | 3 | 0 | 0 | no | 0.2 | 0.2 | dnr after sadm | 24 | 122 | 6.799805 | 125 | 24 | 36.19531 | 280 | null | null | 1.399902 | 141 | 7.459961 | 95 | 18 | 3,430 | null | 0 | no(M2 and SIP pres) | 0 |
4,834 | 56.24597 | 1 | female | 1 | 10 | 10 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 14 | $11-$25k | 0 | 107,025 | 59,218.7812 | 62,037 | 43 | white | 34.398438 | 80 | 0.562988 | 0.450989 | 13 | 0 | 0 | no | null | null | dnr after sadm | 9 | 75 | 13.398438 | 65 | 20 | 36 | null | 2.5 | 18.597656 | 2.099609 | 131 | null | 36 | 55 | 1,600 | null | 5 | <2 mo. follow-up | 5 |
4,835 | 61.15298 | 1 | male | 0 | 5 | 240 | Colon Cancer | Cancer | 1 | 12 | >$50k | 0 | 8,201 | 4,998.1562 | 5,235 | 6 | white | 13.398438 | 10 | 0.865967 | 0.699951 | 1 | 0 | 0 | metastatic | null | null | no dnr | 5 | 100 | null | 75 | 26 | 36.59375 | 254.15625 | null | null | 0.799927 | 136 | 7.389648 | 148 | 21 | null | 0 | 0 | no(M2 and SIP pres) | 0 |
4,836 | 69.42596 | 1 | female | 1 | 6 | 6 | MOSF w/Malig | ARF/MOSF | 1 | 3 | $11-$25k | 37 | 37,687 | 24,268.3906 | 27,492 | 30 | white | 25.5 | 29 | 0.444946 | 0.325989 | 3 | 0 | 0 | yes | 0.05 | 0 | no dnr | 6 | 135 | 22.898438 | 65 | 35 | 36.5 | 200 | 2.799805 | 1.599854 | 6.299805 | 127 | 7.319336 | 91 | 68 | 36 | null | 0 | <2 mo. follow-up | 0 |
4,837 | 49.30298 | 1 | male | 1 | 4 | 4 | MOSF w/Malig | ARF/MOSF | 1 | 12 | null | 0 | 18,720 | 10,866.8438 | 11,675 | 28 | white | 34.398438 | 56 | 0.302979 | 0.190979 | 5 | 0 | 0 | metastatic | 0 | 0 | dnr after sadm | 3 | 60 | 15.298828 | 125 | 10 | 38.19531 | 167.5 | null | null | 0.599976 | 135 | 7.429688 | 94 | 5 | 1,730 | null | null | <2 mo. follow-up | 2.436035 |
4,838 | 42.70499 | 0 | female | 0 | 19 | 801 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 0 | 95,884 | null | null | 20.333328 | black | 20.398438 | 18 | 0.870972 | 0.825928 | 10 | 0 | 0 | no | 0.9 | 0.9 | no dnr | 19 | 125 | 9.5 | 115 | 9 | 38.5 | 164 | null | null | 1.099854 | 136 | 7.459961 | 174 | 26 | 3,335 | null | null | adl>=4 (>=5 if sur) | 2.511231 |
4,839 | 60.36697 | 1 | female | 0 | 6 | 109 | Lung Cancer | Cancer | 1 | 15 | >$50k | 0 | 10,652 | null | null | 9 | white | 16.398438 | 10 | 0.72998 | 0.458984 | 1 | 0 | 0 | metastatic | 1 | 0.95 | no dnr | 6 | 113 | 4.899414 | 115 | 34 | 37.89844 | 215 | null | null | 0.899902 | 142 | 7.459961 | 118 | 13 | 3,480 | 0 | 0 | no(M2 and SIP pres) | 0 |
4,840 | 59.51297 | 0 | male | 0 | 11 | 801 | CHF | COPD/CHF/Cirrhosis | 3 | 12 | $25-$50k | 0 | 8,861 | 6,182.6094 | 5,707 | 14.5 | white | 21.199219 | 22 | 0.86499 | 0.775879 | 1 | 1 | 0 | no | null | null | no dnr | 11 | 72 | 12 | 75 | 4 | 38.39844 | 215 | 2 | null | 1.399902 | 140 | 7.40918 | 128 | 26 | 2,605 | 0 | 0 | no(M2 and SIP pres) | 0 |
4,841 | 81.52197 | 1 | female | 0 | 6 | 118 | Colon Cancer | Cancer | 1 | 15 | null | 0 | 9,687 | 5,528.4688 | 4,374 | 11 | black | 19.199219 | 12 | 0.747925 | 0.487976 | 1 | 0 | 0 | metastatic | 0.8 | 0.5 | no dnr | 6 | 108 | 12.199219 | 115 | 9 | 38.59375 | 157.5 | null | null | 4.299805 | 149 | 7.509766 | 233 | 81 | 3,095 | 4 | 3 | no(M2 and SIP pres) | 3 |
4,842 | 60.65698 | 0 | male | 0 | 27 | 801 | Cirrhosis | COPD/CHF/Cirrhosis | 3 | 4 | null | 0 | 116,117 | 66,416 | 60,614 | 25.5 | white | 23.5 | 32 | 0.695923 | 0.530884 | 3 | 0 | 0 | no | 0.6 | 0.6 | no dnr | 27 | 85 | 4.699219 | 65 | 22 | 36.5 | null | 3.699707 | 0.699951 | 1.5 | 140 | null | 85 | 8 | null | null | 0 | no(M2 and SIP pres) | 0 |
4,843 | 57.53897 | 1 | male | 0 | 4 | 29 | Lung Cancer | Cancer | 1 | 12 | null | 0 | 4,855 | 3,390.8594 | 3,726 | 14 | white | 24.199219 | 26 | 0.562988 | 0.240997 | 1 | 0 | 0 | metastatic | 0.75 | 0.6 | no dnr | 4 | 58 | 14.599609 | 65 | 26 | 38.39844 | 400 | null | null | 0.699951 | 142 | 7.389648 | 141 | 9 | 3,220 | null | 4 | <2 mo. follow-up | 4 |
4,844 | 36.84097 | 0 | female | 0 | 12 | 798 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | under $11k | 41 | null | 28,480.3594 | 27,868 | 44 | black | 29.5 | 59 | 0.704956 | 0.615967 | 1 | 0 | 0 | no | 0.3 | 0.3 | no dnr | 12 | 118 | 14.199219 | 105 | 26 | 38.59375 | 284 | null | 0.899902 | 0.599976 | 141 | 7.439453 | 101 | 3 | 4,340 | null | null | no(M2 and SIP pres) | 2.710449 |
4,845 | 67.49896 | 1 | male | 0 | 6 | 250 | Colon Cancer | Cancer | 1 | 12 | $25-$50k | 0 | 7,342 | 4,205.8242 | 2,525 | 13 | white | 19.898438 | 11 | 0.768921 | 0.521973 | 1 | 0 | 0 | metastatic | 0.8 | 0.7 | no dnr | 6 | 113 | 5.299805 | 68 | 20 | 36.5 | null | 3.699707 | 0.5 | 10.398438 | 138 | null | 72 | 45 | null | 0 | 0 | null | 0 |
4,846 | 61.06497 | 0 | male | 0 | 10 | 798 | Lung Cancer | Cancer | 1 | 20 | null | 0 | 19,506 | 11,892.625 | 11,220 | 17 | white | 17.199219 | 26 | 0.712891 | 0.432983 | 1 | 0 | 0 | metastatic | 1 | 1 | no dnr | 10 | 112 | 6.5 | 125 | 28 | 35.89844 | 110.20312 | null | null | 0.5 | 138 | 7.509766 | 145 | 21 | 3,535 | 0 | 0 | no(M2 and SIP pres) | 0 |
4,847 | 61.65097 | 1 | male | 1 | 16 | 16 | Coma | Coma | 4 | 12 | null | 61 | 44,669 | 26,613.8281 | 26,918 | 29.333328 | black | 20 | 32 | 0.552979 | 0.484985 | 1 | 1 | 0 | no | 0.1 | 0.1 | dnr after sadm | 1 | 71 | 7.099609 | 74 | 16 | 35.79688 | null | null | 0.399963 | 0.799927 | 139 | null | 114 | 12 | 2,050 | null | 3 | <2 mo. follow-up | 3 |
4,848 | 49.125 | 1 | female | 1 | 60 | 60 | MOSF w/Malig | ARF/MOSF | 1 | 12 | >$50k | 9 | null | 197,475.75 | 185,879 | 52 | white | 30.796875 | 52 | 0.407959 | 0.287964 | 2 | 0 | 0 | metastatic | null | null | dnr after sadm | 45 | 72 | 4.799805 | 45 | 20 | 36.29688 | null | 3.899902 | 0.5 | 1.099854 | 139 | null | 104 | 7 | null | null | 1 | null | 1 |
4,849 | 48.67899 | 0 | female | 0 | 8 | 797 | CHF | COPD/CHF/Cirrhosis | 4 | 12 | null | 0 | 8,753 | 5,985.1289 | 5,681 | 13 | white | 21 | 24 | 0.893921 | 0.821899 | 1 | 1 | 0 | no | null | null | no dnr | 8 | 119 | 7 | 128 | 32 | 36.39844 | null | null | null | 0.899902 | 139 | null | 118 | 8 | null | 0 | 0 | SIP>=30 | 0 |
4,850 | 71.90997 | 1 | male | 0 | 22 | 318 | MOSF w/Malig | ARF/MOSF | 2 | 3 | under $11k | 0 | 58,249 | null | null | 22 | other | 26.097656 | 38 | 0.487976 | 0.369995 | 7 | 0 | 0 | metastatic | 0.5 | 0.2 | no dnr | 22 | 77 | 16.199219 | 115 | 6 | 39.39844 | 252.5 | null | null | 0.899902 | 143 | 7.569336 | 176 | 14 | 1,980 | null | 7 | no(M2 and SIP pres) | 7 |
4,851 | 49.21799 | 1 | male | 1 | 6 | 6 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | 12 | under $11k | 44 | 37,986 | 23,976.9844 | 27,007 | 26 | white | 36.09375 | 82 | 0.30896 | 0.128998 | 1 | 0 | 0 | no | 0.5 | 0.5 | dnr after sadm | 1 | 150 | 19.097656 | 140 | 40 | 38.79688 | 187.5 | null | null | 2 | 142 | 7.5 | 158 | 113 | 2,950 | null | 0 | <2 mo. follow-up | 0 |
4,852 | 56.36697 | 1 | male | 1 | 4 | 4 | CHF | COPD/CHF/Cirrhosis | 3 | 14 | $25-$50k | 0 | 15,479 | 8,717.2109 | 8,650 | 36 | white | 32.695313 | 48 | 0.708984 | 0.54895 | 1 | 0 | 0 | no | null | null | no dnr | 4 | 103 | 9.5 | 65 | 28 | 38.19531 | 148.96875 | null | null | 1.199951 | 141 | 7.429688 | 118 | 23 | 925 | 0 | 0 | <2 mo. follow-up | 0 |
4,853 | 73.85394 | 1 | female | 1 | 31 | 31 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 11 | under $11k | 37 | 156,015 | 88,125.1875 | 82,866 | 43.25 | black | 28.097656 | 37 | 0.521973 | 0.405945 | 2 | 1 | 0 | no | 0.5 | 0.5 | dnr after sadm | 16 | 103 | 7.5 | 80 | 20 | 36.29688 | null | 3 | 3.5 | 1 | 133 | null | 105 | 10 | 2,075 | null | null | <2 mo. follow-up | 2.564941 |
4,854 | 66.63098 | 0 | male | 0 | 17 | 796 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 9 | $11-$25k | 0 | 50,995 | null | null | 25 | white | 26.296875 | 22 | 0.766968 | 0.691895 | 1 | 0 | 0 | no | 0.3 | 0.2 | no dnr | 17 | 60 | 20.5 | 100 | 9 | 37 | 180 | 2.599609 | null | 1.099854 | 145 | 7.459961 | 206 | 42 | 1,545 | 0 | 0 | no(M2 and SIP pres) | 0 |
4,855 | 67.46295 | 1 | female | 0 | 19 | 70 | CHF | COPD/CHF/Cirrhosis | 4 | 7 | null | 0 | 62,389 | null | null | 17.666656 | white | 19.398438 | 17 | 0.860962 | 0.769897 | 1 | 0 | 0 | no | null | null | no dnr | 19 | 73 | 15.798828 | 75 | 28 | 36 | 200 | 4.099609 | 0.699951 | 0.699951 | 140 | 7.389648 | 281 | 5 | 1,800 | 5 | null | null | 3.854981 |
4,856 | 22.63699 | 0 | male | 0 | 42 | 795 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | null | 0 | 172,064 | 103,872.812 | 124,299 | 26 | black | 23.699219 | 36 | 0.896973 | 0.859985 | 4 | 0 | 0 | no | null | null | no dnr | 42 | 38 | 14.099609 | 95 | 12 | 35.09375 | 197.5 | 1.899902 | 1 | 3.199707 | 129 | 7.449219 | 244 | 31 | 0 | null | 0 | null | 0 |
4,857 | 58.52197 | 1 | male | 0 | 10 | 65 | CHF | COPD/CHF/Cirrhosis | 3 | 12 | under $11k | 0 | null | 8,245.4297 | 9,055 | 15 | white | 17 | 20 | 0.903931 | 0.837891 | 1 | 1 | 0 | no | 0.9 | 0.8 | no dnr | 10 | 82 | 9.298828 | 112 | 20 | 36.39844 | null | 2.699707 | 2.899902 | 1 | 127 | null | 114 | 31 | 1,900 | 0 | 0 | adl>=4 (>=5 if sur) | 0 |
4,858 | 69.45099 | 1 | female | 0 | 20 | 81 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | null | under $11k | 0 | 45,707 | 26,465.7188 | 29,656 | 22.666656 | black | 22.898438 | 16 | 0.783936 | 0.713989 | 3 | 0 | 0 | no | 0.2 | 0.1 | dnr after sadm | 5 | 147 | 10.699219 | 115 | 25 | 38.5 | 393.3125 | null | null | 0.799927 | 133 | 7.439453 | 161 | 16 | 2,305 | null | 6 | adl>=4 (>=5 if sur) | 6 |
4,859 | 71.18695 | 1 | female | 1 | 4 | 4 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | null | 44 | 69,569 | 40,665.0312 | 37,001 | 25 | black | 32 | 96 | 0.295959 | 0.184998 | 18 | 0 | 0 | no | 0.03 | 0.01 | dnr after sadm | 2 | 67 | 10 | 119 | 26 | 37.69531 | null | 2.099609 | 0.899902 | 0.399963 | 134 | null | 174 | 3 | null | null | null | <2 mo. follow-up | 2.80957 |
4,860 | 44.44098 | 1 | female | 0 | 5 | 96 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | 10 | under $11k | 0 | 5,385 | 3,102.6836 | 3,011 | 10 | black | 29.5 | 44 | 0.727905 | 0.574951 | 1 | 0 | 0 | no | null | null | no dnr | 5 | 102 | 14 | 45 | 12 | 38.29688 | 344 | null | null | 0.899902 | 132 | 7.439453 | 189 | 13 | 2,135 | 1 | null | no(M2 and SIP pres) | 1.166748 |
4,861 | 61.36099 | 1 | male | 0 | 5 | 465 | Colon Cancer | Cancer | 1 | 15 | >$50k | 0 | 9,995 | 5,151.3203 | 2,624 | 13 | white | 20.796875 | 3 | 0.767944 | 0.518921 | 1 | 0 | 0 | metastatic | 0.75 | 0.5 | no dnr | 5 | 125 | 3.799805 | 60 | 28 | 35.29688 | 266.625 | 2.699707 | null | 0.799927 | 137 | 7.449219 | 285 | 13 | 1,955 | 0 | 0 | no(M2 and SIP pres) | 0 |
4,862 | 71.99695 | 1 | male | 0 | 89 | 222 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | null | null | 26 | 207,723 | 127,257.875 | 130,479 | 32.75 | black | 21.5 | 36 | 0.746948 | 0.667969 | 1 | 0 | 0 | no | 0.7 | 0.7 | no dnr | 89 | 100 | 8.5 | 75 | 18 | 36.5 | 256.5 | 4.099609 | 0.399963 | 1 | 139 | 7.40918 | 79 | 13 | 900 | null | 6 | null | 6 |
4,863 | 57.70599 | 1 | male | 0 | 50 | 130 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 16 | null | 0 | 191,559 | 118,099.75 | 133,797 | 14.75 | white | 29.5 | 54 | 0.670898 | 0.575928 | 14 | 0 | 0 | no | null | null | no dnr | 50 | 53 | 16.296875 | 105 | 10 | 37.79688 | 165 | 1.799805 | null | 0.5 | 129 | 7.479492 | 213 | 18 | 3,900 | 2 | 2 | no(M2 and SIP pres) | 2 |
4,864 | 57.34198 | 0 | male | 0 | 18 | 790 | COPD | COPD/CHF/Cirrhosis | 2 | null | null | 0 | 42,913 | 25,772.3906 | 25,675 | 19.333328 | black | 23.199219 | 33 | 0.86499 | 0.776978 | 1 | 0 | 0 | no | 0.7 | 0.7 | no dnr | 18 | 68 | 11.099609 | 145 | 9 | 35 | 220 | null | 0.799927 | 2.399902 | 129 | 7.349609 | 192 | 55 | 2,230 | null | 0 | no(M2 and SIP pres) | 0 |
4,865 | 50.89398 | 1 | female | 0 | 9 | 74 | MOSF w/Malig | ARF/MOSF | 1 | 16 | $25-$50k | 0 | null | 18,112 | 18,462 | 21.5 | white | 22.199219 | 36 | 0.67395 | 0.577881 | 2 | 0 | 0 | metastatic | 0.9 | 0.8 | no dnr | 9 | 75 | 7.799805 | 75 | 32 | 35.89844 | 226.65625 | 2.699707 | 1.899902 | 1.299805 | 141 | 7.339844 | 126 | 48 | 1,550 | 0 | 1 | no(M2 and SIP pres) | 1 |
4,866 | 64.70398 | 0 | male | 0 | 4 | 789 | Colon Cancer | Cancer | 2 | 16 | null | 0 | 20,581 | null | null | 7 | white | 15.298828 | 5 | 0.838989 | 0.647949 | 1 | 1 | 0 | metastatic | null | null | no dnr | 4 | 62 | 7.799805 | 65 | 28 | 36 | null | null | null | 1.799805 | 132 | null | 155 | 45 | 2,390 | 0 | 0 | no(M2 and SIP pres) | 0 |
4,867 | 84.862 | 1 | male | 1 | 7 | 7 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 14 | under $11k | 44 | 34,260 | null | null | 19.5 | white | 31.699219 | 58 | 0.222992 | 0.125 | 13 | 0 | 0 | no | null | null | dnr after sadm | 2 | 100 | 17.699219 | 120 | 30 | 38.29688 | 310 | 2 | 2.699707 | 1.399902 | 139 | 7.419922 | 121 | 48 | 2,330 | null | 6 | <2 mo. follow-up | 6 |
4,868 | 70.77594 | 1 | female | 1 | 12 | 12 | MOSF w/Malig | ARF/MOSF | 2 | 12 | $11-$25k | 44 | 94,253 | 56,570.1562 | 61,229 | 59.5 | white | 49 | 87 | 0.001 | 0 | 16 | 1 | 0 | yes | 0.5 | 0.3 | dnr after sadm | 9 | 62 | 2.5 | 125 | 33 | 37.79688 | 404 | 2.599609 | 1.699951 | 2.199707 | 149 | 7.40918 | 74 | 25 | 1,550 | null | 5 | <2 mo. follow-up | 5 |
4,869 | 55.30698 | 0 | female | 0 | 16 | 788 | COPD | COPD/CHF/Cirrhosis | 1 | 10 | null | 0 | 45,838 | null | null | 23 | black | 18.199219 | 17 | 0.906982 | 0.843994 | 2 | 0 | 0 | no | 0.9 | 0.9 | no dnr | 16 | 122 | 6 | 125 | 26 | 36.19531 | 185.6875 | null | null | 0.699951 | 130 | 7.439453 | 126 | 7 | 2,035 | null | 0 | no(M2 and SIP pres) | 0 |
4,870 | 70.74896 | 0 | male | 0 | 42 | 788 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | null | null | 0 | 153,838 | 86,810.3125 | 86,737 | 40.25 | white | 32.398438 | 56 | 0.621948 | 0.517944 | 1 | 0 | 0 | no | null | null | no dnr | 42 | 48 | 1.799805 | 0 | 24 | 36.09375 | 142.5 | null | null | 0.599976 | 128 | 7.429688 | 36 | 18 | 3,180 | null | null | null | 2.522461 |
4,871 | 84.474 | 1 | female | 0 | 3 | 4 | CHF | COPD/CHF/Cirrhosis | 3 | null | null | 0 | 2,348 | 1,736.6465 | 1,974 | 9 | white | 19.5 | 34 | 0.802979 | 0.681885 | 1 | 1 | 0 | no | null | null | no dnr | 3 | 73 | 4.399414 | 64 | 32 | 38.39844 | 138.3125 | null | null | 0.899902 | 134 | 7.449219 | 210 | 15 | 1,940 | null | null | <2 mo. follow-up | 2.685547 |
4,872 | 53.29999 | 1 | female | 0 | 14 | 19 | Cirrhosis | COPD/CHF/Cirrhosis | 0 | 10 | under $11k | 0 | 16,419 | null | null | 7.333332 | hispanic | 28.296875 | 44 | 0.685913 | 0.517944 | 1 | 0 | 0 | no | null | null | no dnr | 14 | 97 | 5.199219 | 70 | 20 | 37 | null | 3.699707 | 0.599976 | 0.899902 | 140 | null | 98 | 6 | 3,400 | 0 | 6 | <2 mo. follow-up | 6 |
4,873 | 45.26797 | 1 | male | 1 | 31 | 31 | MOSF w/Malig | ARF/MOSF | 1 | 18 | under $11k | 44 | 88,046 | 56,097.2188 | 64,470 | 26.75 | black | 44.59375 | 84 | 0.018997 | 0.004 | 5 | 0 | 0 | yes | 0.2 | 0.1 | dnr after sadm | 3 | 20 | 12.298828 | 0 | 0 | 37.79688 | 154 | 3.399902 | 0.799927 | 1.5 | 135 | 7.40918 | 255 | 31 | 1,310 | null | 0 | <2 mo. follow-up | 0 |
4,874 | 70.88599 | 1 | female | 0 | 31 | 46 | MOSF w/Malig | ARF/MOSF | 2 | 12 | $11-$25k | 0 | 91,599 | 53,839.2812 | 57,139 | 25.25 | white | 21.796875 | 34 | 0.636963 | 0.534912 | 3 | 1 | 0 | metastatic | 0.95 | 0.9 | no dnr | 31 | 78 | 14 | 65 | 26 | 37.59375 | null | null | null | 0.699951 | 137 | null | 365 | 30 | 1,280 | null | 0 | <2 mo. follow-up | 0 |
4,875 | 75.90094 | 1 | male | 0 | 4 | 645 | CHF | COPD/CHF/Cirrhosis | 3 | 12 | $11-$25k | 0 | 3,281 | 2,380.8574 | 2,666 | 9 | white | 21.898438 | 31 | 0.800903 | 0.678955 | 1 | 1 | 0 | no | 0.85 | 0.8 | no dnr | 4 | 112 | 11.798828 | 45 | 35 | 39 | 188.5625 | null | null | 0.799927 | 133 | 7.399414 | 148 | 14 | 3,950 | null | null | SIP>=30 | 2.245606 |
4,876 | 58.58197 | 0 | male | 0 | 18 | 786 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 8 | $11-$25k | 9 | 62,225 | 34,993.1562 | 37,089 | 31.666656 | black | 35.695313 | 78 | 0.546997 | 0.43396 | 2 | 1 | 0 | no | 0.5 | 0.45 | no dnr | 18 | 80 | 13 | 72 | 20 | 36.89844 | null | 3.299805 | 0.599976 | 0.799927 | 138 | null | 171 | 3 | 2,500 | null | 0 | no(M2 and SIP pres) | 0 |
4,877 | 76.12299 | 1 | male | 1 | 7 | 7 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 0 | 81,539 | 46,428 | 46,704 | 42.5 | white | 33.398438 | 52 | 0.366943 | 0.248993 | 16 | 0 | 0 | yes | 0.2 | 0.1 | dnr after sadm | 2 | 45 | 11.398438 | 145 | 41 | 38.19531 | 151.40625 | 2.699707 | 1.399902 | 0.699951 | 139 | 7.05957 | 68 | 7 | 2,005 | null | null | <2 mo. follow-up | 2.240723 |
4,878 | 56.89798 | 0 | female | 0 | 39 | 786 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | null | 0 | 167,108 | null | null | 33.75 | white | 27.296875 | 46 | 0.741943 | 0.660889 | 6 | 0 | 0 | no | 0.5 | 0.4 | no dnr | 39 | 65 | 6.899414 | 70 | 26 | 37.79688 | 352 | null | null | 4.299805 | 131 | 7.519531 | 237 | 94 | 585 | null | 0 | null | 0 |
4,879 | 79.31799 | 1 | male | 0 | 75 | 104 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 12 | $11-$25k | 44 | null | 205,665.625 | 192,444 | 38.25 | white | 37.398438 | 68 | 0.134979 | 0.061996 | 1 | 0 | 0 | yes | 0.5 | 0.4 | dnr after sadm | 57 | 128 | 19.296875 | 160 | 14 | 35.09375 | 330 | null | null | 1 | 136 | 7.40918 | 138 | 26 | 1,700 | null | 0 | adl>=4 (>=5 if sur) | 0 |
4,880 | 49.10599 | 0 | female | 0 | 34 | 783 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | under $11k | 0 | 147,854 | 81,525.25 | 88,502 | 31.75 | black | 29.296875 | 44 | 0.769897 | 0.695923 | 2 | 0 | 0 | no | 0.7 | 0.65 | no dnr | 34 | 48 | 15.298828 | 145 | 15 | 39 | 140 | 2.5 | 4 | 3.599609 | 131 | 7.399414 | 103 | 23 | 1,600 | null | 0 | no(M2 and SIP pres) | 0 |
4,881 | 49.28098 | 1 | male | 0 | 11 | 14 | Cirrhosis | COPD/CHF/Cirrhosis | 3 | 13 | under $11k | 100 | 17,741 | null | null | 15.5 | white | 35 | 53 | 0.089996 | 0.014999 | 1 | 0 | 0 | no | 0.3 | 0.1 | dnr after sadm | 1 | 58 | 19.097656 | 190 | 47 | 37.69531 | 176 | 2.199707 | 11.298828 | 0.799927 | 143 | 7.449219 | 234 | 7 | 7,790 | null | 0 | <2 mo. follow-up | 0 |
4,882 | 77.17999 | 1 | female | 0 | 88 | 264 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 16 | under $11k | 26 | null | 412,953 | 427,935 | 34.25 | white | 36.5 | 79 | 0.197998 | 0.105988 | 86 | 1 | 0 | no | 0.2 | 0.5 | no dnr | 88 | 112 | 9.5 | 65 | 20 | 37.79688 | null | null | 0.599976 | 1 | 137 | null | 117 | 12 | 1,880 | null | 0 | adl>=4 (>=5 if sur) | 0 |
4,883 | 51.504 | 0 | female | 0 | 22 | 782 | Coma | Coma | 1 | 11 | $25-$50k | 9 | 52,590 | null | null | 30.666656 | white | 17.699219 | 8 | 0.827881 | 0.792969 | 2 | 0 | 0 | no | 0.8 | 0.6 | no dnr | 22 | 108 | 78.1875 | 105 | 10 | 37.79688 | 167.34375 | null | 1.199951 | 0.899902 | 149 | 7.349609 | 99 | 22 | 2,170 | null | 0 | no(M2 and SIP pres) | 0 |
4,884 | 65.56598 | 1 | female | 0 | 18 | 452 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | $25-$50k | 0 | 57,122 | 33,227.5938 | 32,585 | 29 | white | 30.699219 | 60 | 0.621948 | 0.517944 | 1 | 0 | 0 | yes | null | null | no dnr | 18 | 72 | 22.898438 | 125 | 13 | 37.89844 | 164 | null | null | 2.899902 | 130 | 7.349609 | 124 | 58 | 1,066 | null | 7 | SIP>=30 | 7 |
4,885 | 64.66498 | 0 | female | 0 | 15 | 781 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | 8 | $11-$25k | 0 | null | 21,407.9375 | 27,319 | 17 | white | 17.398438 | 36 | 0.882935 | 0.840942 | 1 | 1 | 0 | no | 0.8 | 0.75 | no dnr | 15 | 93 | 14.898438 | 75 | 30 | 36.39844 | 305 | 3.099609 | 1.899902 | 0.899902 | 132 | 7.429688 | 150 | 30 | 3,685 | 1 | 0 | no(M2 and SIP pres) | 0 |
4,886 | 75.77295 | 0 | male | 0 | 23 | 781 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 16 | >$50k | 0 | 226,055 | 124,220.188 | 123,581 | 28.333328 | white | 27.796875 | 47 | 0.593994 | 0.485962 | 32 | 0 | 0 | no | 0.65 | 0.6 | no dnr | 23 | 117 | 6.5 | 100 | 20 | 36.29688 | null | null | 0.599976 | 1 | 138 | null | 103 | 15 | null | null | 5 | SIP>=30 | 5 |
4,887 | 71.19495 | 1 | male | 1 | 8 | 8 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 14 | $25-$50k | 0 | 38,463 | 23,534.8594 | 25,944 | 32 | white | 47.5 | 74 | 0.196991 | 0.104996 | 1 | 0 | 0 | no | 0.4 | 0.4 | dnr after sadm | 3 | 80 | 8.298828 | 109 | 22 | 36.19531 | null | null | 2.199707 | 1.5 | 138 | null | 82 | 27 | 2,800 | null | 0 | <2 mo. follow-up | 0 |
4,888 | 37.83698 | 0 | male | 0 | 10 | 780 | MOSF w/Malig | ARF/MOSF | 1 | 16 | $25-$50k | 0 | 46,743 | null | null | 20 | asian | 21.796875 | 26 | 0.668945 | 0.572998 | 5 | 0 | 0 | metastatic | null | null | no dnr | 10 | 79 | 7.199219 | 72 | 20 | 38.69531 | null | 2.899902 | 0.599976 | 0.899902 | 141 | null | 97 | 5 | 4,700 | 0 | 0 | no(M2 and SIP pres) | 0 |
4,889 | 47.13498 | 0 | male | 0 | 26 | 780 | Coma | Coma | 0 | 17 | $11-$25k | 44 | 72,007 | 45,311.5312 | 47,142 | 23 | white | 22.398438 | 22 | 0.626953 | 0.564941 | 6 | 0 | 0 | no | null | null | no dnr | 26 | 112 | 18.199219 | 135 | 33 | 38.39844 | 243.3125 | 2 | 1.299805 | 0.599976 | 145 | 7.419922 | 118 | 15 | 1,705 | null | 0 | no(M2 and SIP pres) | 0 |
4,890 | 70.49097 | 1 | male | 1 | 3 | 3 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | $11-$25k | 0 | null | 13,936.1016 | 16,877 | 39 | white | 44.898438 | 82 | 0.273987 | 0.165985 | 1 | 0 | 0 | no | null | null | dnr after sadm | 3 | 71 | 3.099609 | 113 | 28 | 35.09375 | null | null | null | 1.299805 | 135 | null | 107 | 18 | null | null | null | <2 mo. follow-up | 1.950439 |
4,891 | 69.42896 | 1 | female | 0 | 122 | 253 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 14 | null | 0 | 367,125 | 220,730.75 | 206,405 | 39.5 | black | 35.796875 | 79 | 0.544922 | 0.430969 | 1 | 0 | 0 | no | 0.5 | 0.5 | no dnr | 122 | 147 | 7.799805 | 120 | 6 | 36.09375 | 253.3125 | 2.399902 | 3.899902 | 4.099609 | 147 | 7.399414 | 177 | 54 | 820 | null | 1 | adl>=4 (>=5 if sur) | 1 |
4,892 | 65.54999 | 1 | male | 1 | 24 | 24 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | null | 0 | 219,969 | 114,773.188 | 124,871 | 44.666657 | white | 38.195313 | 60 | 0.290955 | 0.181 | 20 | 0 | 0 | yes | null | null | dnr after sadm | 18 | 106 | 10.398438 | 55 | 16 | 35.59375 | null | 3.399902 | 0.5 | 1.099854 | 140 | null | 191 | 14 | 3,650 | null | null | <2 mo. follow-up | 2.347168 |
4,893 | 58.66098 | 0 | male | 0 | 4 | 778 | COPD | COPD/CHF/Cirrhosis | 1 | 10 | under $11k | 0 | 3,723 | null | null | 8 | black | 20.699219 | 43 | 0.883911 | 0.806885 | 1 | 0 | 0 | no | 0.6 | 0.5 | no dnr | 4 | 65 | 11.599609 | 105 | 14 | 38.19531 | 312 | null | null | 1 | 135 | 7.359375 | 144 | 21 | 1,260 | 0 | null | no(M2 and SIP pres) | 0.494751 |
4,894 | 61.82898 | 1 | female | 1 | 30 | 30 | COPD | COPD/CHF/Cirrhosis | 4 | 21 | >$50k | 0 | 43,942 | 27,844.7969 | 28,191 | 17.25 | white | 27.699219 | 64 | 0.73291 | 0.580933 | 1 | 0 | 0 | yes | 0.5 | 0.4 | dnr after sadm | 9 | 118 | 14.699219 | 75 | 10 | 35.89844 | 253.3125 | null | 3 | 1.199951 | 147 | 7.489258 | 239 | 18 | 930 | null | 2 | <2 mo. follow-up | 2 |
4,895 | 77.01294 | 0 | female | 0 | 57 | 776 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | null | 0 | 177,611 | 102,840.75 | 100,930 | 44.25 | white | 31 | 52 | 0.620972 | 0.515991 | 1 | 0 | 0 | no | 0.5 | 0.125 | no dnr | 57 | 65 | 10.5 | 120 | 12 | 37.79688 | 178 | 2.799805 | 3.599609 | 2.599609 | 149 | 7.389648 | 74 | 26 | 710 | null | 0 | SIP>=30 | 0 |
4,896 | 64.586 | 1 | male | 0 | 16 | 197 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 14 | null | 9 | 53,737 | 30,612.4062 | 34,432 | 26.333328 | white | 18.699219 | 27 | 0.843994 | 0.790894 | 2 | 0 | 0 | no | 0.4 | 0.35 | no dnr | 16 | 98 | 15.398438 | 75 | 24 | 36.69531 | 271.375 | null | 0.699951 | 2.899902 | 138 | 7.289062 | 182 | 59 | null | 1 | 0 | no(M2 and SIP pres) | 0 |
4,897 | 69.20197 | 0 | male | 0 | 22 | 775 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 12 | $11-$25k | 9 | 66,688 | 43,376.4688 | 49,564 | 13 | white | 25.296875 | 27 | 0.651978 | 0.552979 | 35 | 0 | 0 | no | 0.9 | 0.88 | no dnr | 22 | 108 | 1 | 110 | 33 | 38.09375 | 230 | 2.599609 | 0.699951 | 0.899902 | 145 | 7.539062 | 99 | 27 | 2,375 | 7 | 7 | adl>=4 (>=5 if sur) | 7 |
4,898 | 63.28299 | 1 | male | 0 | 17 | 82 | Colon Cancer | Cancer | 1 | 18 | >$50k | 0 | 23,392 | null | null | 18.666656 | white | 12.298828 | 12 | 0.872925 | 0.713989 | 1 | 0 | 0 | metastatic | 0.8 | 0.6 | no dnr | 17 | 55 | 28 | 70 | 30 | 36.09375 | 214.28125 | 1 | 18.199219 | 8 | 136 | 7.389648 | 84 | 101 | 940 | null | 0 | null | 0 |
4,899 | 70.04797 | 1 | male | 0 | 13 | 122 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 9 | under $11k | 0 | 56,994 | 33,252.2812 | 35,871 | 43.5 | white | 20.097656 | 18 | 0.842896 | 0.78894 | 1 | 0 | 0 | no | 0.75 | 0.7 | no dnr | 13 | 42 | 4.899414 | 75 | 11 | 37.59375 | 324 | null | null | 1.599854 | 127 | 7.479492 | 210 | 49 | 3,955 | null | 1 | no(M2 and SIP pres) | 1 |
4,900 | 59.32599 | 1 | male | 0 | 6 | 196 | COPD | COPD/CHF/Cirrhosis | 2 | 10 | null | 0 | 11,088 | null | null | 16 | white | 25.296875 | 22 | 0.831909 | 0.725952 | 1 | 0 | 0 | no | 0.8 | 0.8 | no dnr | 6 | 48 | 22.097656 | 115 | 8 | 38.69531 | 220 | 2.299805 | 0.699951 | 1.399902 | 144 | 7.429688 | 227 | 18 | 3,620 | 0 | null | no(M2 and SIP pres) | 0.494751 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.